ARQT Arcutis Biotherapeutics, Inc. - Common stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 5, 2026
$25.16
· % 处于52周区间
· 高于低点
· 至高点
$19.3052周低点
$31.7752周高点
市值 (MRQ)
$3.16B
P/E (TTM)
114.4
EPS (TTM)
$0.22
收入 (TTM)
$464M
ARQT 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$25.16
市值 (MRQ)
$3.16B
P/E (TTM)
114.4
EPS (TTM)
$0.22
收入 (TTM)
$464M
ROE (TTM)
15.9%
负债/权益 (MRQ)
0.5
52周区间
$19–$32
ARQT 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$376M2020-12-31 → 2025-12-31
EPS$-0.132019-12-31 → 2025-12-31
自由现金流$-6M2020-12-31 → 2025-12-31
净利率6.1%2023-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | ARQT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 114.45年均值 ≈-48.8 | ≈-48.8 | 27.9 | 估值过高 | |
| P/S (TTM) | 6.85年均值 ≈7.7 | ≈7.7 | 11.9 | 低估 | |
| 市净率 (MRQ) | 14.35年均值 ≈10.9 | ≈10.9 | 4.9 | 估值过高 | |
| EV / EBITDA (企业价值 / EBITDA) | -259.25年均值 ≈-104.4 | ≈-104.4 | · | · | |
| 股价/自由现金流 (TTM) | 80.75年均值 ≈-194.5 | ≈-194.5 | · | · | |
| 市现率 (TTM) | 80.45年均值 ≈-217.5 | ≈-217.5 | · | · | |
| EV / Revenue (市值/营收) | 8.45年均值 ≈8.5 | ≈8.5 | · | · | |
| EV / FCF (市值/自由现金流) | -502.25年均值 ≈-198.2 | ≈-198.2 | · | · | |
| 市净率（有形资产） (MRQ) | 15.35年均值 ≈8.7 | ≈8.7 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | ARQT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 7.4%5年均值 ≈-157.7% | ≈-157.7% | 12.5% | 持平 | |
| EBITDA Margin (息税折旧摊销前利润率) | -3.2%5年均值 ≈-157.7% | ≈-157.7% | 12.5% | 持平 | |
| 净利润率 (TTM) | 6.1%5年均值 ≈-171.8% | ≈-171.8% | 10.2% | 持平 | |
| ROA (TTM) | 6.8%5年均值 ≈-37.0% | ≈-37.0% | -13.8% | 顶尖 | |
| ROE (TTM) | 15.9%5年均值 ≈-162.1% | ≈-162.1% | -10.7% | 持平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | ARQT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 0.55年均值 ≈1.2 | ≈1.2 | · | · | |
| 流动比率 (MRQ) | 2.95年均值 ≈4.8 | ≈4.8 | 4.6 | 低流动性 | |
| Quick Ratio (速动比率) | 1.55年均值 ≈1.9 | ≈1.9 | 4.1 | 低流动性 | |
| 长期负债/股东权益 (MRQ) | 0.55年均值 ≈1.2 | ≈1.2 | · | · |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | ARQT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 91.3%5年均值 ≈612.7% | ≈612.7% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 367.3% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | ARQT | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 1.05年均值 ≈0.6 | ≈0.6 | 0.4 | 顶尖 | |
| Inventory Turnover (库存周转率) | 2.05年均值 ≈1.3 | ≈1.3 | · | · | |
| Receivables Turnover (应收账款周转率) | 3.45年均值 ≈3.6 | ≈3.6 | 8.4 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$1.1M | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
56.7%
下次报告
十月 26, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 4, 2026 | $0.11 | $0.04 | 150.6% |
| 2026年3月31日 | $-0.09 | $-0.08 | -7.4% | |
| 2025年12月31日 | $0.13 | $0.12 | 12.4% | |
| 2025年9月30日 | $0.06 | $-0.10 | 158.9% | |
| 2025年6月30日 | $-0.13 | $-0.16 | 19.4% | |
| 2025年3月31日 | $-0.20 | $-0.21 | 6.6% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $376M | $197M | $60M | $4M | $0 | $0 | |
| Cost of Revenue | $37M | $19M | $5M | $754.0K | $0 | · | |
| R&D Expense | $77M | $76M | $111M | $182M | $146M | $115M | |
| SG&A Expense | $275M | $229M | $185M | $122M | $61M | $21M | |
| Operating Expenses | $388M | $325M | $301M | $305M | $207M | $137M | |
| Operating Income | $-12M | $-128M | $-241M | $-302M | $-207M | $-137M | |
| Interest Expense | · | · | $30M | $16M | $0 | $0 | |
| Other Non-op | $443.0K | $47.0K | $-731.0K | $6M | $173.0K | $967.0K | |
| Income Tax | $1M | $647.0K | $3M | $0 | $0 | $0 | |
| Net Income | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| EPS (Basic) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| EPS (Diluted) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| Shares (Basic) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| Shares (Diluted) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| EBITDA | $-12M | $-128M | $-241M | · | · | $-137M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $71M | $88M | $54M | $96M | $65M | |
| Receivables | $146M | $73M | $26M | $8M | $0 | · | |
| Inventory | $23M | $15M | $13M | $8M | $0 | · | |
| Prepaid Expense | $21M | $20M | $19M | $11M | $14M | $7M | |
| Current Assets | $411M | $336M | $330M | $437M | $403M | $293M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | $532.0K | $78.0K | |
| Intangibles | $15M | $9M | $6M | $7M | $0 | · | |
| Other Non-current Assets | $1M | $596.0K | $596.0K | $78.0K | $78.0K | $78.0K | |
| Total Assets | $433M | $349M | $341M | $449M | $408M | $298M | |
| Accounts Payable | $13M | $14M | $12M | $9M | $7M | $7M | |
| Accrued Liabilities | $116M | $67M | $34M | $28M | $26M | $15M | |
| Current Liabilities | $130M | $81M | $47M | $38M | $33M | $23M | |
| Capital Leases | $5M | $3M | $3M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $431.0K | $570.0K | $849.0K | $0 | $25.0K | $82.0K | |
| Total Liabilities | $243M | $191M | $253M | $240M | $110M | $28M | |
| Long-term Debt | $109M | $107M | $202M | $198M | $72M | $0 | |
| Total Debt | $109M | $107M | $202M | · | · | · | |
| Common Stock | $12.0K | $12.0K | $9.0K | $6.0K | $5.0K | $4.0K | |
| Paid-in Capital | $1.33B | $1.28B | $1.07B | $930M | $706M | $473M | |
| Retained Earnings | $-1.14B | $-1.12B | $-982M | $-720M | $-408M | $-202M | |
| AOCI | $-44.0K | $-7.0K | $4.0K | $-1M | $-255.0K | $-2.0K | |
| Stockholders' Equity | $189M | $158M | $89M | $210M | $298M | $271M | |
| Liabilities + Equity | $433M | $349M | $341M | $449M | $408M | $298M | |
| Shares Outstanding | 123,333,000 | 117,848,033 | 96,787,343 | 61,037,403 | 50,255,614 | 43,338,438 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $42M | $39M | $33M | $24M | $8M | |
| Deferred Tax | $54.0K | $-152.0K | $0 | $0 | $0 | · | |
| Amort. of Intangibles | $5M | $2M | $750.0K | $312.0K | $0 | $0 | |
| Operating Cash Flow | $-6M | $-112M | $-247M | $-258M | $-175M | $-113M | |
| CapEx | $686.0K | $143.0K | $428.0K | $333.0K | $995.0K | $321.0K | |
| Investing Cash Flow | $-30M | $29M | $180M | $-87M | $-76M | $-182M | |
| Debt Issued | · | $0 | $0 | $125M | $74M | $0 | |
| Net Debt Issued | $0 | $-100M | $0 | · | · | · | |
| Stock Issued | $0 | $162M | $0 | $162M | $207M | $128M | |
| Net Stock Activity | $0 | $162M | $0 | · | · | $128M | |
| Financing Cash Flow | $7M | $66M | $101M | $302M | $282M | $298M | |
| Net Change in Cash | $-29M | $-17M | $34M | $-43M | $31M | $3M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | |
| Free Cash Flow | $-6M | $-112M | $-247M | · | · | $-113M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| Net Margin | -4.3% | -71.2% | -439.8% | · | · | · | |
| EBITDA Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| ROA | -4.1% | -40.6% | -66.3% | · | · | -67.0% | |
| ROE | -9.8% | -89.1% | -387.2% | · | · | -61.2% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 4.1 | 7.1 | · | · | 13.0 | |
| Quick Ratio | 1.5 | 1.8 | 2.4 | · | · | 2.9 | |
| Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| Interest Coverage | · | · | -8.1 | · | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.2 | · | · | · | |
| Inventory Turnover | 2.0 | 1.4 | 0.5 | · | · | · | |
| Receivables Turnover | 3.4 | 4.0 | 3.5 | · | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.54 | $1.34 | $0.92 | · | · | $6.24 | |
| Revenue / Share | $2.96 | $1.62 | $0.86 | · | · | · | |
| Cash Flow / Share | $-0.04 | $-0.93 | $-3.56 | · | · | · | |
| Cash / Share | $0.35 | $0.61 | $0.91 | · | · | $1.50 | |
| EPS (TTM) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 91.3% | 229.7% | 1517.1% | · | · | · | |
| Revenue CAGR 3Y | 367.3% | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $376M | $197M | $60M | $4M | $0 | $0 | |
| Net Income TTM | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| Market Cap | $3.58B | $1.64B | $313M | · | · | $1.22B | |
| Enterprise Value | $3.65B | $1.68B | $426M | · | · | · | |
| P/E | -223.4 | -12.0 | -0.9 | -2.6 | -5.0 | -7.4 | |
| P/S | 9.5 | 8.4 | 5.2 | · | · | · | |
| P/B | 18.9 | 10.4 | 3.5 | · | · | 4.5 | |
| P / Tangible Book | 20.5 | 11.1 | 3.8 | 4.5 | 3.5 | 4.5 | |
| P / Cash Flow | -636.7 | -14.6 | -1.3 | · | · | -10.8 | |
| P / FCF | -567.5 | -14.6 | -1.3 | · | · | -10.8 | |
| EV / EBITDA | -298.3 | -13.1 | -1.8 | · | · | · | |
| EV / FCF | -578.0 | -14.9 | -1.7 | · | · | · | |
| EV / Revenue | 9.7 | 8.5 | 7.1 | · | · | · | |
| Earnings Yield | -0.45% | -8.3% | -117.0% | -38.2% | -20.2% | -13.5% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $130M | $105M | $130M | $99M | $82M | $66M | $71M | $45M | $31M | $50M | $14M | $38M | $5M | $3M | $3M | $725.0K | |
| Cost of Revenue | $11M | $10M | $12M | $9M | $7M | $9M | $7M | $6M | $3M | $3M | $2M | $1M | $776.0K | $783.0K | · | · | |
| R&D Expense | $20M | $31M | $20M | $20M | $19M | $18M | $14M | $20M | $19M | $23M | $24M | $26M | $25M | $35M | $34M | $70M | |
| SG&A Expense | $82M | $74M | $79M | $62M | $69M | $64M | $58M | $59M | $58M | $55M | $49M | $48M | $46M | $43M | $37M | $35M | |
| Operating Expenses | $113M | $114M | $111M | $91M | $96M | $90M | $79M | $84M | $81M | $81M | $75M | $75M | $72M | $79M | $71M | $105M | |
| Operating Income | $16M | $-9M | $18M | $9M | $-15M | $-25M | $-8M | $-39M | $-50M | $-32M | $-61M | $-37M | $-67M | $-76M | $-68M | $-105M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $8M | $7M | $7M | · | $5M | |
| Interest Income | $2M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-157.0K | $-20.0K | $-6M | $2M | $20.0K | $193.0K | $-13M | $4M | $5M | $4M | $-10M | $3M | $3M | $3M | $3M | $2M | |
| Income Tax | $136.0K | $93.0K | $470.0K | $80.0K | $342.0K | $279.0K | $323.0K | $0 | $0 | $324.0K | $90.0K | $3M | $0 | $0 | $0 | $0 | |
| Net Income | $15M | $-11M | $17M | $7M | $-16M | $-25M | $-11M | $-42M | $-52M | $-35M | $-66M | $-45M | $-71M | $-80M | $-72M | $-108M | |
| EPS (Basic) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| EPS (Diluted) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| Shares (Basic) | 130,522,000 | 129,365 | · | 127,623,000 | 126,997,000 | 126,037 | · | 124,302,000 | 123,481,000 | 111,048,525 | · | 61,727,278 | 61,430,620 | 61,169,089 | · | 57,091,743 | |
| Shares (Diluted) | 135,898,000 | 129,365 | · | 132,885,000 | 126,997,000 | 126,037 | · | 124,302,000 | 123,481,000 | 111,048,525 | · | 61,727,278 | 61,430,620 | 61,169,089 | · | 57,091,743 | |
| EBITDA | $16M | $-9M | · | $9M | $-15M | $-25M | · | $-39M | $-50M | · | · | $-37M | · | · | · | $-105M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $35M | $43M | $47M | $73M | $53M | $71M | $135M | $84M | $190M | · | $107M | $105M | $81M | · | $82M | |
| Receivables | $155M | $144M | $146M | $115M | $107M | $85M | $73M | $60M | $43M | $37M | · | $19M | $17M | $13M | · | $2M | |
| Inventory | $39M | $37M | $23M | $22M | $16M | $17M | $15M | $14M | $14M | $13M | · | $14M | $10M | $9M | · | $4M | |
| Prepaid Expense | $35M | $32M | $21M | $20M | $19M | $23M | $20M | $18M | $14M | $13M | · | $20M | $12M | $13M | · | $12M | |
| Current Assets | $468M | $438M | $411M | $349M | $333M | $324M | $336M | $424M | $435M | $468M | · | $282M | $309M | $368M | · | $497M | |
| PP&E (Net) | $872.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $4M | · | · | · | $4M | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | · | · | · | · | $2M | $2M | $1M | · | $993.0K | |
| Intangibles | $14M | $14M | $15M | $15M | $16M | $16M | $9M | $10M | $6M | $6M | · | $7M | $7M | $7M | · | $7M | |
| Other Non-current Assets | $2M | $2M | $1M | $596.0K | $596.0K | $596.0K | $596.0K | $596.0K | $595.0K | $596.0K | · | $596.0K | $596.0K | $78.0K | · | $78.0K | |
| Total Assets | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Accounts Payable | $7M | $18M | $13M | $6M | $15M | $25M | $14M | $19M | $8M | $13M | · | $13M | $17M | $12M | · | $9M | |
| Accrued Liabilities | $147M | $137M | $116M | $93M | $88M | $66M | $67M | $53M | $43M | $34M | · | $28M | $19M | $24M | · | $28M | |
| Current Liabilities | $160M | $163M | $130M | $100M | $104M | $91M | $81M | $172M | $51M | $47M | · | $42M | $37M | $37M | · | $37M | |
| Capital Leases | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $4M | |
| Other Non-current Liabilities | $431.0K | $431.0K | $431.0K | $360.0K | $360.0K | $360.0K | $570.0K | $420.0K | $194.0K | $306.0K | · | · | · | · | · | $0 | |
| Total Liabilities | $268M | $270M | $243M | $213M | $213M | $201M | $191M | $281M | $258M | $254M | · | $246M | $240M | $240M | · | $238M | |
| Long-term Debt | $109M | $109M | $109M | $108M | $108M | $108M | $107M | $205M | $204M | $203M | · | $201M | $200M | $199M | · | $197M | |
| Total Debt | $109M | $109M | · | $108M | $108M | $108M | · | $205M | $204M | · | · | $201M | · | · | · | $197M | |
| Common Stock | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $1.36B | $1.34B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.27B | $1.26B | $1.24B | · | $963M | $952M | $940M | · | $920M | |
| Retained Earnings | $-1.13B | $-1.15B | $-1.14B | $-1.16B | $-1.16B | $-1.15B | $-1.12B | $-1.11B | $-1.07B | $-1.02B | · | $-916M | $-871M | $-800M | · | $-648M | |
| AOCI | $-656.0K | $-514.0K | $-44.0K | $-62.0K | $-35.0K | $-140.0K | $-7.0K | $533.0K | $-294.0K | $-133.0K | · | $-184.0K | $-292.0K | $-414.0K | · | $-2M | |
| Stockholders' Equity | $221M | $190M | $189M | $158M | $139M | $143M | $158M | $157M | $186M | $225M | $89M | $47M | $81M | $140M | $210M | $271M | |
| Liabilities + Equity | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Shares Outstanding | 125,591,000 | 125,042,000 | 123,332,672 | 120,288,146 | 119,797,738 | 119,137,785 | 117,848,033 | 116,998,829 | 116,480,267 | 115,505,437 | · | 61,858,044 | 61,630,018 | 61,357,932 | · | 60,908,641 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $11M | $10M | $10M | $10M | $10M | $9M | $10M | $13M | $10M | $9M | $10M | $11M | $9M | $9M | $9M | |
| Amort. of Intangibles | $563.0K | $562.0K | $563.0K | $562.0K | $563.0K | $3M | $313.0K | $1M | $200.0K | $188.0K | $-188M | $188M | $200.0K | $188.0K | $187.0K | $125.0K | |
| Operating Cash Flow | $13M | $2M | $26M | $-2M | $324.0K | $-30M | $-748.0K | $-35M | $-45M | $-32M | $-56M | $-44M | $-66M | $-80M | $-71M | $-68M | |
| CapEx | $158.0K | $0 | $0 | $0 | $78.0K | $608.0K | $0 | $143.0K | $0 | $0 | $6.0K | $64.0K | $276.0K | $82.0K | $123.0K | $6.0K | |
| Investing Cash Flow | $-15M | $-11M | $-34M | $-25M | $17M | $12M | $35M | $85M | $-62M | $-29M | $-62M | $46M | $89M | $108M | $42M | $-197M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $162M | $0 | $0 | $0 | $0 | $0 | $162M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $1M | $4M | $1M | $1M | $395.0K | $-97M | $394.0K | $1M | $162M | $99M | $867.0K | $1M | $100.0K | $962.0K | $285M | |
| Net Change in Cash | $-641.0K | $-8M | $-4M | $-26M | $19M | $-18M | $-64M | $51M | $-106M | $101M | $-19M | $2M | $24M | $27M | $-28M | $20M | |
| Free Cash Flow | · | $2M | · | · | · | $-31M | · | · | · | · | · | · | · | · | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| Net Margin | 11.6% | -10.7% | · | 7.5% | -19.5% | -38.1% | · | -92.8% | -169.6% | · | · | -117.5% | · | · | · | -14856.4% | |
| EBITDA Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| ROA | 3.6% | -2.8% | · | 1.8% | -4.0% | -6.1% | · | -11.4% | -13.7% | · | · | -11.2% | · | · | · | -24.0% | |
| ROE | 8.3% | -6.8% | · | 4.7% | -9.8% | -13.6% | · | -40.8% | -39.2% | · | · | -28.2% | · | · | · | -34.0% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.7 | · | 3.5 | 3.2 | 3.6 | · | 2.5 | 8.5 | · | · | 6.7 | · | · | · | 13.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.6 | 1.7 | 1.5 | · | 1.1 | 2.5 | · | · | 3.0 | · | · | · | 2.3 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.7 | 0.8 | 0.8 | · | 1.3 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.7 | 0.8 | 0.8 | · | 0.7 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4.9 | · | · | · | -21.4 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | · | · | 0.1 | · | · | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.4 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.0 | 0.9 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.0 | · | · | 3.5 | · | · | · | 0.6 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.76 | $1.52 | · | $1.31 | $1.16 | $1.20 | · | $1.34 | $1.60 | · | · | $0.76 | · | · | · | $4.45 | |
| Revenue / Share | $0.96 | $814.73 | · | $0.75 | $0.64 | $0.52 | · | $0.36 | $0.25 | · | · | $0.62 | · | · | · | $0.01 | |
| Cash Flow / Share | · | $17.31 | · | · | · | $-0.24 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.27 | $0.28 | · | $0.39 | $0.61 | $0.45 | · | $1.15 | $0.72 | · | · | $1.74 | · | · | · | $1.34 | |
| EPS (TTM) | $0.22 | $-0.02 | · | $-0.36 | $-0.75 | $-1.04 | · | $-1.65 | $-2.05 | $-3.52 | · | $-4.39 | $-5.67 | $-5.78 | · | $-5.91 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $464M | $416M | · | $318M | $263M | $213M | · | $139M | $132M | $96M | · | $49M | $9M | $4M | · | $725.0K | |
| Net Income TTM | $29M | $-2M | · | $-44M | $-93M | $-130M | · | $-196M | $-199M | $-231M | · | $-268M | $-326M | $-320M | · | $-311M | |
| Market Cap | $3.29B | $2.95B | · | $2.27B | $1.68B | $1.86B | · | $1.09B | $1.08B | · | · | $328M | · | · | · | $1.16B | |
| Enterprise Value | $3.37B | $3.02B | · | $2.33B | $1.71B | $1.92B | · | $1.16B | $1.20B | · | · | $422M | · | · | · | $1.28B | |
| P/E | 119.2 | -1178.0 | · | -52.4 | -18.7 | -15.0 | · | -5.6 | -4.5 | -2.8 | · | -1.2 | -1.7 | -1.9 | · | -3.2 | |
| P/S | 7.1 | 7.1 | · | 7.1 | 6.4 | 8.8 | · | 7.8 | 8.2 | · | · | 6.7 | · | · | · | 1605.5 | |
| P/B | 14.9 | 15.5 | · | 14.3 | 12.1 | 13.1 | · | 6.9 | 5.8 | · | · | 7.0 | · | · | · | 4.3 | |
| P / Tangible Book | 15.9 | 16.8 | · | 15.9 | 13.7 | 14.8 | · | 7.4 | 6.0 | 5.2 | · | 8.2 | 8.0 | 5.1 | · | 4.4 | |
| P / Cash Flow | · | 1315.8 | · | · | · | -61.3 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 7.3 | 7.3 | · | 7.3 | 6.5 | 9.0 | · | 8.3 | 9.1 | · | · | 8.6 | · | · | · | 1764.4 | |
| Earnings Yield | 0.84% | -0.08% | · | -1.9% | -5.3% | -6.7% | · | -17.7% | -22.0% | -35.5% | · | -82.7% | -59.5% | -52.5% | · | -30.9% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $376M | $197M | $60M | $4M | $0 |
| 营业利润率 % | -3.2% | -65.3% | -404.5% | · | · |
| 净收入 | $-16M | $-140M | $-262M | $-311M | $-206M |
| 稀释后每股收益 (EPS) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.6 | 0.7 | 2.3 | · | · |
| 流动比率 | 3.2 | 4.1 | 7.1 | · | · |
| 速动比率 | 1.5 | 1.8 | 2.4 | · | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-6M | $-112M | $-247M | · | · |
机构持有人 (13F) 289 家申报者 · $3.6B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
289
持有价值
$3.6B
新仓位
39
已退出持仓
33
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 39 (-4 与上一季度对比) | 33 (-9 与上一季度对比) | 93 (-10 与上一季度对比) | 101 (+13 与上一季度对比) | -1.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $326098140 | 12437000 | 8.97% | 股份 |
| BlackRock, Inc. | $276502120 | 10545466 | 7.61% | 股份 |
| Frazier Life Sciences Management, L.P. | $258909678 | 9874511 | 7.12% | 股份 |
| Rubric Capital Management LP | $216880749 | 8271577 | 5.97% | 股份 |
| VANGUARD GROUP INC | $210654301 | 7253936 | 5.80% | 股份 |
| Polar Capital Holdings Plc | $173234098 | 6606945 | 4.77% | 股份 |
| STATE STREET CORP | $152674865 | 5822840 | 4.20% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $130805182 | 4988756 | 3.60% | 股份 |
| MORGAN STANLEY | $116705607 | 4451014 | 3.21% | 股份 |
| JENNISON ASSOCIATES LLC | $110623703 | 4219058 | 3.04% | 股份 |
| D. E. Shaw & Co., Inc. | $103558748 | 3949609 | 2.85% | 股份 |
| UBS Group AG | $87391654 | 3333015 | 2.40% | 股份 |
| BANK OF AMERICA CORP /DE/ | $78330441 | 2987431 | 2.16% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $78214092 | 2982446 | 2.15% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $63688511 | 2429005 | 1.75% | 股份 |
| ORBIMED ADVISORS LLC | $53541240 | 2042000 | 1.47% | 股份 |
| FRANKLIN RESOURCES INC | $50630354 | 1930982 | 1.39% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $50474363 | 1925031 | 1.39% | 股份 |
| GOLDMAN SACHS GROUP INC | $43744582 | 1668367 | 1.20% | 股份 |
| JANUS HENDERSON GROUP PLC | $43684303 | 1854566 | 1.20% | 股份 |
| OBERWEIS ASSET MANAGEMENT INC/ | $35998513 | 1372941 | 0.99% | 股份 |
| GILDER GAGNON HOWE & CO LLC | $34432392 | 1313211 | 0.95% | 股份 |
| Pivotal bioVenture Partners Investment Advisor LLC | $33175720 | 1265283 | 0.91% | 股份 |
| BAMCO INC /NY/ | $32856806 | 1253120 | 0.90% | 股份 |
| CITADEL ADVISORS LLC | $30415567 | 1160014 | 0.84% | 股份 |
| FEDERATED HERMES, INC. | $29487772 | 1124629 | 0.81% | 股份 |
| Perpetual Ltd | $29095206 | 1109657 | 0.80% | 股份 |
| Aberdeen Group plc | $28800336 | 1098411 | 0.79% | 股份 |
| Jones Hill Capital LP | $28571960 | 1089701 | 0.79% | 股份 |
| NORTHERN TRUST CORP | $27755837 | 1058575 | 0.76% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $27555489 | 1050934 | 0.76% | 股份 |
| Ensign Peak Advisors, Inc | $25552281 | 974534 | 0.70% | 股份 |
| Candriam S.C.A. | $24880817 | 949839 | 0.68% | 股份 |
| Driehaus Capital Management LLC | $23032330 | 878426 | 0.63% | 股份 |
| Nuveen, LLC | $21874324 | 834261 | 0.60% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $21372918 | 815138 | 0.59% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21284137 | 811752 | 0.59% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $17406855 | 663877 | 0.48% | 股份 |
| FISHMAN JAY A LTD/MI | $15601031 | 595005 | 0.43% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $14789968 | 564072 | 0.41% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $14349629 | 547278 | 0.39% | 股份 |
| Squarepoint Ops LLC | $14099726 | 537747 | 0.39% | 股份 |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $13110000 | 500000 | 0.36% | 股份 |
| Nearwater Capital Markets, Ltd | $12761274 | 486700 | 0.35% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12218520 | 466000 | 0.34% | 股份 |
| MARSHALL WACE, LLP | $11716827 | 446866 | 0.32% | 股份 |
| Privium Fund Management B.V. | $10471403 | 399367 | 0.29% | 股份 |
| NORGES BANK | $10286106 | 392300 | 0.28% | 股份 |
| DEUTSCHE BANK AG\ | $10033923 | 382682 | 0.28% | 股份 |
| Patient Square Capital LP | $9701400 | 370000 | 0.27% | 股份 |
激进投资者及 5%+ 股东 3 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P., FHM LIFE SCIENCES VIII, L.P., FHM LIFE SCIENCES VIII, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×8 申报 | 2025年8月20日 | 7.50% | 修订 | 被动投资 | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital LLC ×7 申报 | 2022年8月26日 | · | 初始申报 | · | SEC |
| Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP ×4 申报 | 2022年8月8日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 26 位内幕人士 · 12 位高管 · 14 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Todd Franklin Watanabe | Reporting Person's title: President and Chief Executive Officer | 2026年8月3日 S | 717203 | 0 | 13 | $-5324269 |
| Latha Vairavan | SVP Chief Financial Officer | 2026年5月11日 S | 85978 | 0 | 6 | $-148496 |
| David Joseph Topper | Chief Financial Officer | 2025年4月2日 S | 182774 | 0 | 0 | $0 |
| John W Smither | Chief Financial Officer | 2024年2月13日 D | 11365 | 0 | 0 | $0 |
| Scott L Burrows | Chief Financial Officer | 2023年3月6日 S | 59115 | 0 | 0 | $0 |
| Masaru Matsuda | Reporting Person's title: EVP, Chief Legal Officer | 2026年9月16日 S | 112508 | 0 | 18 | $-2207960 |
| Patrick Burnett | Reporting Person's title: EVP, Chief Medical Officer | 2026年8月19日 S | 117592 | 0 | 18 | $-2019340 |
| Larry Todd Edwards | Reporting Person's title: EVP, Chief Commercial Officer | 2026年2月27日 A | 175178 | 0 | 6 | $-968374 |
| Matthew Richard Moore | SVP and Chief Business Officer | 2024年5月2日 S | 145505 | 0 | 0 | $0 |
| Kenneth A. Lock | Chief Commercial Officer | 2023年3月6日 S | 63429 | 0 | 0 | $0 |
| Patricia A. Turney | SVP, Operations | 2023年3月6日 S | 62862 | 0 | 0 | $0 |
| David W Osborne | Chief Technical Officer | 2023年3月6日 S | 268854 | 0 | 0 | $0 |
| Howard G. Welgus | 董事 | 2026年9月15日 M | 35841 | 0 | 14 | $-2425410 |
| Terrie Curran | 董事 | 2026年8月27日 M | 23526 | 0 | 3 | $-984061 |
| Christopher Peetz | 董事 | 2026年7月15日 A | 4315 | 0 | 0 | $0 |
| Sue-Jean Lin | 董事 | 2026年6月15日 S | 27567 | 0 | 2 | $-898455 |
| Neha Krishnamohan | 董事 | 2026年6月5日 A | 27901 | 0 | 2 | $-939510 |
| Amit Munshi | 董事 | 2026年6月5日 A | 9799 | 0 | 0 | $0 |
| Halley E Gilbert | 董事 | 2026年6月5日 A | 27901 | 0 | 1 | $-455457 |
| Keith R Leonard | 董事 | 2026年6月5日 A | 27901 | 0 | 1 | $-997116 |
| Patrick J. Heron | 董事 | 2026年6月5日 A | 32213 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | 董事 | 2025年6月12日 A | 867826 | 0 | 0 | $0 |
| Joseph L Turner | 董事 | 2022年6月1日 A | 4312 | 0 | 0 | $0 |
| Jonathan Silverstein | 董事 | 2020年10月2日 P | 902286 | 0 | 0 | $0 |
| Daniel Estes | 董事 | 2020年2月27日 A | · | 0 | 0 | $0 |
| Ricky Sun | · | 2021年6月9日 A | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 37 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| RZG · Invesco Exchange-Traded Fund Trust | 1.71% | 77200 SH | 2026年10月1日 | 每日 |
| PSCH · Invesco Exchange-Traded Fund Trus... | 1.63% | 109981 SH | 2026年10月1日 | 每日 |
| BBP · ETFis Series Trust I | 1.52% | 55666 NS | 2026年7月31日 | N-PORT |
| GURU · Global X Funds | 1.46% | 33313 NS | 2026年7月31日 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1.43% | 199300 SH | 2026年10月1日 | 每日 |
| LABU · Direxion Shares ETF Trust | 0.54% | 98745 NS | 2026年7月31日 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trus... | 0.42% | 64059 SH | 2026年10月1日 | 每日 |
| FYC · First Trust Exchange-Traded Alpha... | 0.41% | 197027 NS | 2026年7月31日 | N-PORT |
| NUSC · Nushares ETF Trust | 0.22% | 107502 NS | 2026年7月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.22% | 8879 SH | 2026年10月1日 | 每日 |
| IBB · iShares Trust | 0.19% | 842985 SH | 2026年9月11日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.18% | 122691 SH | 2026年8月19日 | 每日 |
| IWO · iShares Trust | 0.18% | 1074467 SH | 2026年9月11日 | 每日 |
| PWS · Pacer Funds Trust | 0.15% | 1349 NS | 2026年7月31日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.13% | 66540 NS | 2026年7月31日 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.12% | 3883 NS | 2026年7月31日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.11% | 29355 NS | 2026年7月31日 | N-PORT |
| RSSL · Global X Funds | 0.10% | 54786 NS | 2026年7月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.09% | 658480 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.09% | 2915298 SH | 2026年9月11日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.08% | 17847 NS | 2026年7月31日 | N-PORT |
| ISCG · iShares Trust | 0.08% | 34084 SH | 2026年9月11日 | 每日 |
| ESML · iShares Trust | 0.07% | 88662 SH | 2026年9月11日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.07% | 55080 SH | 2026年8月19日 | 每日 |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.06% | 5568 SH | 2026年10月1日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.05% | 46067 SH | 2026年10月1日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 53372 NS | 2026年7月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.04% | 335913 SH | 2026年8月19日 | 每日 |
| RWJ · Invesco Exchange-Traded Fund Trus... | 0.03% | 24646 SH | 2026年10月1日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 1307970 SH | 2026年8月19日 | 每日 |
| WSML · iShares Trust | 0.02% | 6362 SH | 2026年9月11日 | 每日 |
| TILT · FlexShares Trust | 0.00% | 3204 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 152928 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 31652 SH | 2026年9月10日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3565928 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9521 SH | 2026年8月19日 | 每日 |
| ISCB · iShares Trust | · | 4781 SH | 2026年9月11日 | 每日 |
ARQT 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 14 位分析师
买入
中位数目标
$38.00
+51.0%
4 28.6%
强烈买入
8 57.1%
买入
2 14.3%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
7 位分析师 · 2026-10-01平均目标 $37.00 +47.1%
← 低于所有目标
当前价格 $25.16
最低$34.00
平均值$37.00
最高$40.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 5, 2026 申报